Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000902664-25-002933
Filing Date
2025-07-08
Accepted
2025-07-08 16:31:39
Documents
1
Effectiveness Date
2025-07-08
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8518
  Complete submission text file 0000902664-25-002933.txt   9686
Mailing Address 750 LEXINGTON AVENUE 30TH FLOOR NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE 30TH FLOOR NEW YORK NY 10022 (212) 317-7500
Avicenna Life Sci US Fund LP (Filer) CIK: 0002028627 (see all company filings)

EIN.: 934638445 | State of Incorp.: DE
Type: D/A | Act: 33 | File No.: 021-518021 | Film No.: 251111362